Jump to content

Choose locationPalo Alto Medical Foundation
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location
Sutter Health
  • Video Visits
  • Find Doctors
  • Find Locations
  • Treatments & Services
  • Locations
  • Sign in or Enroll
    • Video Visits
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • PAMF
  • Research
  • Investigators
  • Christopher Jones
Content

Investigator Christopher Jones, MD

Christopher Jones, MD

View profile  
Dr. Christopher Jones is a board-certified radiation oncologist who specializes in the use of ionizing radiation to treat cancer, focusing on tumors of the head and neck, prostate, and brain. He investigates optimal use of radiation therapy (radiotherapy) techniques including intensity modulated radiation therapy (IMRT), high-dose brachytherapy, and image-guided radiation therapy. Dr. Jones is a Principal Investigator for Radiation Therapy Oncology Group (RTOG) National Cancer Institute-sponsored oncology group clinical trials. He has authored numerous publications and abstracts on radiotherapy and imaging techniques to assess cancer progression, predict tumor recurrence after surgery and radiotherapy, and visualize response to treatment. Dr. Jones lectures nationally and internationally on the role of radiation therapy in the management of head and neck cancers.


Sutter Health Research Enterprise
2800 L Street, #10
Sacramento, CA, 95816
(916) 454-6600  
simr@sutterhealth.org

Primary Research Interests

  • Brain Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Prostate Cancer

Related Clinical Trials

Adjuvant (ECOG-ACRIN EA3191)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Added to Radiation or Given by Itself Compared to the Usual Treatment of Chemotherapy With Ra

Investigator: Christopher Jones MD

Status: Active, Recruiting

Adjuvant (NRG BN003)

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Investigator: Christopher Jones MD

Status: Active, Recruiting

Adjuvant (RTOG 3506 STEEL)

A Randomized Phase II Trial of Salvage Radiotherapy with Standard vs Enhanced Androgen Deprivation Therapy (with Enzalutamide)

Investigators: Christopher Jones MD, Sivakumar Reddy M.D., Seth A Rosenthal Radiation Oncologist, David S Yee M.D., MPH

Status: Active, Recruiting

Adjuvant NRG HN001

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Investigator: Christopher Jones MD

Status: Active, Recruiting

First Line or Neoadjuvant (NRG-HN005)

De-intensified Radiation Therapy With Cisplatin or Nivolumab in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

Investigator: Christopher Jones MD

Status: Active, Recruiting

Locally Advanced (NRG BN010)

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Investigator: Christopher Jones MD

Status: Active, Recruiting

Locally Advanced (NRG GU005)

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Investigator: Christopher Jones MD

Status: Active, Recruiting

Locally Advanced (NRG HN004) Temporarily on Hold

Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin

Investigator: Christopher Jones MD

Status: Active, Not Recruiting

Locally Advanced (NRG HN009)

Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Investigator: Christopher Jones MD

Status: Active, Recruiting

Locally Advanced (RTOG 1216)

Randomized Phase II/III Trial of Adjuvant Radiation Therapy (RT) with Cisplatin, Docetaxel Cetuximab, or Cisplatin Atezolizumab in Pathologic High Risk Squamous

Investigator: Christopher Jones MD

Status: Active, Recruiting

Locally Advanced or Metastatic (NRG CC003)

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer

Investigator: Christopher Jones MD

Status: Active, Recruiting

Metastatic (NRG-BN009)

Testing the Addition of HA-WBRT to SRS in People With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier SRS

Investigator: Christopher Jones MD

Status: Active, Recruiting

Neoadjuvant (COMPPARE)

A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer (COMPPARE)

Investigator: Christopher Jones MD

Status: Active, Recruiting

The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

About Sutter

  • About Our Network
  • Annual Report
  • Awards
  • Community Benefit
  • Contact Us
  • News
  • Giving
  • Find Care

  • Birth Centers
  • Care Centers
  • Emergency Rooms
  • Hospitals
  • Imaging
  • Labs
  • Surgery Centers
  • Urgent Care
  • Walk-In Care
  • View All >
  • Featured Services

  • Behavioral Health
  • Cancer Services
  • Family Medicine
  • Home Health and Hospice
  • Orthopedics
  • Pediatrics
  • Pregnancy
  • Primary Care
  • Women's Health
  • View All >
  • Patient Resources

  • Accepted Health Plans
  • Classes and Events
  • Estimate Costs
  • Health and Wellness
  • Medical Records
  • Medicare Advantage
  • My Health Online
  • Pay a Bill
  • Symptom Checker
  • Our Team

  • For Employees
  • Physician Careers
  • Recruiting Events
  • Residencies and Fellowships
  • Sutter Careers
  • Vendors
  • Volunteers
    • ADA Accessibility
    • Contact
    • Privacy
    • Do Not Sell My Personal Information

    • LinkedIn Opens new window
    • YouTube Opens new window
    • Facebook Opens new window
    • Twitter Opens new window
    • Glassdoor Opens new window
    • Instagram Opens new window

    Copyright © 2022 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

    Cookie Policy

    We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

    Privacy Policy Cookie Preferences